{
    "eid": "2-s2.0-84905594748",
    "title": "Risk of newly detected infections and cervical abnormalities in women seropositive for naturally acquired human papillomavirus type 16/18 antibodies: Analysis of the control arm of PATRICIA",
    "cover-date": "2014-08-15",
    "subject-areas": [
        {
            "$": "Immunology and Allergy",
            "@code": "2723"
        },
        {
            "$": "Infectious Diseases",
            "@code": "2725"
        }
    ],
    "keywords": [
        "Cervical abnormality",
        "HPV",
        "Infection",
        "Naturally acquired antibodies",
        "Risk reduction"
    ],
    "authors": [
        "Xavier Castellsagu\u00e9"
    ],
    "citedby-count": 47,
    "ref-count": 35,
    "ref-list": [
        "Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study",
        "Sustained efficacy and immunogenicity of the human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine: analysis of a randomised placebo-controlled trial up to 6\u00b74 years",
        "Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women",
        "Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases",
        "Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions",
        "Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women",
        "A virus-like particle enzyme-linked immunosorbent assay detects serum antibodies in a majority of women infected with human papillomavirus type 16",
        "Prevalence of antibodies to human papillomavirus (HPV) type 16 virus-like particles in relation to cervical HPV infection among college women",
        "Serum antibodies to human papillomavirus (HPV) pseudovirions correlate with natural infection for 13 genital HPV types",
        "Determinants of seropositivity among HPV-16/18 DNA positive young women",
        "Association of HPV types 6, 11, 16, and 18 DNA detection and serological response in unvaccinated adolescent women",
        "Sexual behaviour and papillomavirus exposure in cervical intraepithelial neoplasia: A population-based case-control study",
        "Comparison of human papillomavirus types 16, 18, and 6 capsid antibody responses following incident infection",
        "Stability over time of serum antibody levels to human papillomavirus type 16",
        "Seroreactivity to Human Papillomavirus (HPV) Types 16, 18, or 31 and Risk of Subsequent HPV Infection: Results from a Population-Based Study in Costa Rica",
        "Human papillomavirus capsid antibody response to natural infection and risk of subsequent HPV infection in HIV-positive and HIV-negative women",
        "Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection",
        "Natural seroconversion to high-risk human papillomaviruses (hrHPVs) is not protective against related HPV genotypes",
        "Risk factors for subsequent cervicovaginal human papillomavirus (HPV) infection and the protective role of antibodies to HPV-16 virus-like particles",
        "Epidemiological study of Anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections",
        "A competitive serological assay shows naturally acquired immunity to human papillomavirus infections in the guanacaste natural history study",
        "Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial",
        "Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial",
        "Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial",
        "Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR",
        "Correlation between direct ELISA, single epitope-based inhibition ELISA and pseudovirion-based neutralization assay for measuring anti-HPV-16 and anti-HPV-18 antibody response after vaccination with the AS04-adjuvanted HPV-16/18 cervical cancer vaccine",
        "Prevalence and risk factors for cervical HPV infection and abnormalities in young adult women at enrolment in the multinational PATRICIA trial",
        "Differences in incidence and co-occurrence of vaccine and nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33",
        "Durable antibody responses following one dose of the bivalent human papillomavirus L1 virus-like particle vaccine in the Costa Rica vaccine trial",
        "Sustained immunogenicity and efficacy of the HPV-16/18 AS04-adjuvanted vaccine: Up to 8.4 years of follow-up",
        "Seroprevalence and correlates of human papillomavirus 16/18 seropositivity among young women in Costa Rica",
        "The natural history of human papillomavirus type 16 capsid antibodies among a cohort of university women",
        "Incidence, duration, and reappearance of type-specific cervical human papillomavirus infections in young women",
        "Immunogenicity testing in human papillomavirus virus-like-particle vaccine trials",
        "Direct comparison of HPV16 serological assays used to define HPV-na\u00efve women in HPV vaccine trials"
    ],
    "affiliation": [
        {
            "affiliation-city": "Manchester",
            "affilname": "Health Innovation Manchester",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Wavre",
            "affilname": "GlaxoSmithKline Pharmaceuticals SA/NV",
            "affiliation-country": "Belgium"
        },
        {
            "affiliation-city": "Philadelphia",
            "affilname": "GlaxoSmithKline, USA",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Manila",
            "affilname": "University of the Philippines College of Medicine",
            "affiliation-country": "Philippines"
        },
        {
            "affiliation-city": "Quezon City",
            "affilname": "University of the Philippines",
            "affiliation-country": "Philippines"
        },
        {
            "affiliation-city": "Leuven",
            "affilname": "KU Leuven\u2013 University Hospital Leuven",
            "affiliation-country": "Belgium"
        },
        {
            "affiliation-city": "Edmonton",
            "affilname": "University of Alberta",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Campinas",
            "affilname": "Universidade Estadual de Campinas",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Melbourne",
            "affilname": "University of Melbourne",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Sydney",
            "affilname": "The University of Sydney",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Taipei",
            "affilname": "National Taiwan University College of Medicine",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Albuquerque",
            "affilname": "UNM Health Sciences Center",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Tampere",
            "affilname": "Tampere School of Public Health",
            "affiliation-country": "Finland"
        },
        {
            "affiliation-city": "London",
            "affilname": "Barts and The London School of Medicine and Dentistry",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Wurzburg",
            "affilname": "Stiftung Juliusspital",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Helsinki",
            "affilname": "Vaestoliitto",
            "affiliation-country": "Finland"
        },
        {
            "affiliation-city": "Hospitalet de Llobregat",
            "affilname": "Institute Catala Oncologia",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "Curitiba",
            "affilname": "Universidade Federal do Parana",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Porto Alegre",
            "affilname": "Hospital de Clinicas de Porto Alegre",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Edegem",
            "affilname": "Universitair Ziekenhuis Antwerpen",
            "affiliation-country": "Belgium"
        },
        {
            "affiliation-city": "Rockville",
            "affilname": "National Cancer Institute (NCI)",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Winnipeg",
            "affilname": "University of Manitoba",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Melbourne",
            "affilname": "Murdoch Children's Research Institute",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Mexico",
            "affilname": "Instituto Mexicano del Seguro Social",
            "affiliation-country": "Mexico"
        },
        {
            "affiliation-city": "Helsinki",
            "affilname": "Helsingin Yliopisto",
            "affiliation-country": "Finland"
        },
        {
            "affiliation-city": "Perth",
            "affilname": "The Kids Research Institute Australia",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Catalonia",
            "affilname": "RTICC",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "Melbourne",
            "affilname": "Royal Women's Hospital",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Hamburg",
            "affilname": "Facharzt f\u00fcr Frauenheilkunde und Geburtshilfe",
            "affiliation-country": "Germany"
        }
    ],
    "funding": [
        "National Cancer Institute",
        "National Cancer Institute"
    ]
}